BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 17634845)

  • 1. The role of Tc-99m (V) DMSA scintigraphy in the diagnosis and follow-up of lung cancer lesions.
    Ergün EL; Kara PO; Gedik GK; Kars A; Türker A; Caner B
    Ann Nucl Med; 2007 Jul; 21(5):275-83. PubMed ID: 17634845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of pentavalent Tc-99m DMSA scintigraphy in small cell and nonsmall cell lung cancers.
    Atasever T; Gündoğdu C; Vural G; Kapucu LO; Karalezli A; Unlü M
    Nuklearmedizin; 1997 Oct; 36(7):223-7. PubMed ID: 9394361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of metastatic bone disease with pentavalent 99Tc(m)-dimercaptosuccinic acid: a comparison with whole-body scanning and 4/24 hour quantitation of vertebral lesions.
    Sahin M; Basoglu T; Bernay I; Yapici O; Canbaz F; Yalin T
    Nucl Med Commun; 2000 Mar; 21(3):251-8. PubMed ID: 10823327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of Tc-99m (V) DMSA scintigraphy in the evaluation of superscan on bone scintigraphy.
    Yüksel D; Ilgan S; Arslan N; Uğur O; Oztürk E; Bayhan H
    Clin Nucl Med; 2000 Mar; 25(3):193-6. PubMed ID: 10698416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tc-99m(V) DMSA imaging. A new approach to studying metastases from breast carcinoma.
    Kashyap R; Babbar A; Sahai I; Prakash R; Soni NL; Chauhan UP
    Clin Nucl Med; 1992 Feb; 17(2):119-22. PubMed ID: 1314148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary lung cancer SPECT imaging with pentavalent technetium-99m-DMSA.
    Hirano T; Otake H; Yoshida I; Endo K
    J Nucl Med; 1995 Feb; 36(2):202-7. PubMed ID: 7830114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using technetium-99m (V) dimercaptosuccinic acid to detect malignancies from single solid masses in the lungs.
    Kao CH; Wang SJ; Wey SP; Shen LH; Ting G; Yeh SH
    Eur J Nucl Med; 1992; 19(10):890-3. PubMed ID: 1333404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of 99m-Tc MIBI and 99m-Tc(V) DMSA scintigraphy in evaluation of breast mass lesions.
    Ambrus E; Rajtár M; Ormándi K; Séra T; Tószegi A; Láng J; Pávics L; Csernay L
    Anticancer Res; 1997; 17(3B):1599-605. PubMed ID: 9179201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of metabolic and receptor imaging in recurrent medullary thyroid carcinoma with histopathological findings.
    Adams S; Baum RP; Hertel A; Schumm-Draeger PM; Usadel KH; Hör G
    Eur J Nucl Med; 1998 Sep; 25(9):1277-83. PubMed ID: 9724377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thallium-201-chloride and technetium-99m-MIBI SPECT of primary and metastatic lung carcinoma.
    Kashitani N; Makihara S; Maeda T; Eda R; Takeyama H; Hiraki Y
    Oncol Rep; 1999; 6(1):127-33. PubMed ID: 9864415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tc-99m-(V)-DMSA: the new sensitive and specific radiopharmaceutical for imaging metastases of medullary thyroid carcinomas?
    Becker W; Börner W; Reiners C
    Horm Metab Res Suppl; 1989; 21():38-42. PubMed ID: 2553574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pentavalent Tc-99m dimercaptosuccinic acid imaging of hepatocellular carcinoma.
    Wang SJ; Lin WY; Wey SP; Shen LH; Ting G
    Neoplasma; 1999; 46(4):246-8. PubMed ID: 10613606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The detection of nasopharynx carcinoma in technetium-99m (V) dimercaptosuccinic acid SPECT imaging.
    Kao CH; Wang SJ; Wey SP; Shen LH; Ting G; Yeh SH
    Clin Nucl Med; 1993 Apr; 18(4):321-3. PubMed ID: 8386992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pentavalent 99Tcm-DMSA imaging in patients with bone metastases.
    Lam AS; Kettle AG; O'Doherty MJ; Coakley AJ; Barrington SF; Blower PJ
    Nucl Med Commun; 1997 Oct; 18(10):907-14. PubMed ID: 9392790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analogy between tumor uptake of technetium(V)-99m dimercaptosuccinic acid (DMSA) and technetium-99m-MDP.
    Wulfrank DA; Schelstraete KH; Small F; Fallais CJ
    Clin Nucl Med; 1989 Aug; 14(8):588-93. PubMed ID: 2553315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
    Lind P; Gallowitsch HJ
    Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technetium-99m tetrofosmin single photon emission computed tomography in the evaluation of suspected lung cancer.
    Schillaci O; Monteleone F; D'Andrea N; Picardi V; Cangemi R; Cangemi V; Scopinaro F
    Cancer Biother Radiopharm; 1999 Apr; 14(2):129-34. PubMed ID: 10850296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 99mTc(V)DMSA quantitatively predicts 188Re(V)DMSA distribution in patients with prostate cancer metastatic to bone.
    Blower PJ; Kettle AG; O'Doherty MJ; Coakley AJ; Knapp FF
    Eur J Nucl Med; 2000 Sep; 27(9):1405-9. PubMed ID: 11007525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technetium-99m(V)-DMSA and thallium-201 in brain tumor imaging: correlation with histology and malignant grade.
    Hirano T; Otake H; Kazama K; Wakabayashi K; Zama A; Shibasaki T; Tamura M; Endo K
    J Nucl Med; 1997 Nov; 38(11):1741-9. PubMed ID: 9374344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative radionuclide imaging of metastatic insular carcinoma of the thyroid: value of technetium-99m-(V)DMSA.
    Yen TC; King KL; Yang AH; Liu RS; Yeh SH
    J Nucl Med; 1996 Jan; 37(1):78-80. PubMed ID: 8544007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.